Bicycle Therapeutics is a clinical-stage pharmaceutical company developing Bicycle molecules—fully synthetic short peptides constrained into two loops—for diseases underserved by existing therapeutics. Key candidates include nuzefatide pevedotin (BDC targeting EphA2) in Phase I/II and Phase II trials for solid tumors and pancreatic cancer, zelenectide pevedotin (BDC targeting Nectin-4), BT7480 (Bicycle TICA targeting Nectin-4/CD137), and BT1702 (BRC targeting MT1-MMP). The company also collaborates with biopharmaceutical partners to apply its phage display platform beyond oncology.
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2025-12-31 | 0001104659-26-028971 | EDGAR | 118K words |
| 2025-02-25 | 2024-12-31 | 0001558370-25-001438 | EDGAR | 122K words |
| 2024-02-20 | 2023-12-31 | 0001558370-24-001324 | EDGAR | 125K words |
| 2023-02-28 | 2022-12-31 | 0001558370-23-002238 | EDGAR | 118K words |
| 2022-03-01 | 2021-12-31 | 0001558370-22-002457 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001558370-21-002758 | EDGAR | — |
| 2020-03-10 | 2019-12-31 | 0001558370-20-002278 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-30 | 2026-06-30 | 0001104659-26-088457 | EDGAR | 69K words |
| 2025-10-30 | 2025-09-30 | 0001104659-25-104010 | EDGAR | 71K words |
| 2025-08-08 | 2025-06-30 | 0001558370-25-010843 | EDGAR | 70K words |
| 2025-05-01 | 2025-03-31 | 0001558370-25-006049 | EDGAR | 74K words |
| 2024-10-31 | 2024-09-30 | 0001558370-24-014004 | EDGAR | 80K words |
| 2024-08-06 | 2024-06-30 | 0001558370-24-010949 | EDGAR | 80K words |
| 2024-05-02 | 2024-03-31 | 0001558370-24-006453 | EDGAR | 78K words |
| 2023-11-02 | 2023-09-30 | 0001558370-23-017317 | EDGAR | 80K words |
| 2023-08-03 | 2023-06-30 | 0001558370-23-013057 | EDGAR | 78K words |
| 2023-05-04 | 2023-03-31 | 0001558370-23-007979 | EDGAR | 74K words |
| 2022-11-03 | 2022-09-30 | 0001558370-22-016140 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001558370-22-012050 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-20 | 0001104659-26-099221 | EDGAR | 1K words |
| 2026-07-30 | 0001104659-26-088455 | EDGAR | 3K words |
| 2026-03-17 | 0001104659-26-028954 | EDGAR | 4K words |
| 2026-02-03 | 0001104659-26-009501 | EDGAR | 2K words |
| 2026-01-12 | 0001104659-26-002706 | EDGAR | 1K words |
| 2025-10-30 | 0001104659-25-104004 | EDGAR | 3K words |
| 2025-09-08 | 0001104659-25-088238 | EDGAR | 1K words |
| 2025-08-08 | 0001104659-25-075435 | EDGAR | 3K words |
| 2025-06-17 | 0001104659-25-060316 | EDGAR | 1K words |
| 2025-05-01 | 0001104659-25-043014 | EDGAR | 2K words |
135 total filings indexed. 106 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001761612 |
| Ticker | BCYC |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | X0 |
| Website | https://www.bicycletherapeutics.com |
| Listed | 2019-05-23 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BCYC (~200 tokens, structured JSON with cryptographic provenance)